The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).
 
Amanda Psyrri
Honoraria - AstraZeneca; Bayer; BMS; Genesis Pharmaceuticals; Merck Serono; MSD Oncology; Pfizer; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; MSD Oncology; Pfizer; Rakuten Medical
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
Myrto Moutafi
No Relationships to Disclose
 
Georgia-Angeliki Koliou
No Relationships to Disclose
 
George Papaxoinis
No Relationships to Disclose
 
Niki Gavrielatou
No Relationships to Disclose
 
Panagiota Economopoulou
No Relationships to Disclose
 
Ioannis Kotsantis
No Relationships to Disclose
 
Maria Gkotzamanidou
No Relationships to Disclose
 
Maria Anastasiou
No Relationships to Disclose
 
Dimitrios G. Pectasides
No Relationships to Disclose
 
Aileen Fernandez
No Relationships to Disclose
 
Vesal Yaghoobi
No Relationships to Disclose
 
Saba Shafi
No Relationships to Disclose
 
Ioannis Vathiotis
No Relationships to Disclose
 
Thazin Nwe Aung
No Relationships to Disclose
 
Stavros Gkolfinopoulos
No Relationships to Disclose
 
Periklis Foukas
No Relationships to Disclose
 
George Fountzilas
Stock and Other Ownership Interests - ARIAD; ARIAD (I); Daiichi Sankyo; Deciphera (I); FORMYCON; Genprex; Genprex (I); Rafael Holdings
Honoraria - AstraZeneca
Consulting or Advisory Role - Novartis; Pfizer; Roche
Speakers' Bureau - LEO Pharma (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - K.A.M Oncology/Hematology (I); Merck (I); Pfizer (I)
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen; Bristol-Myers Squibb; Ventana Medical Systems
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Cepheid; Daiichi Sankyo; GlaxoSmithKline; Konica Minolta; Merck; NanoString Technologies; NextCure; PAIGE.AI; Perkin Elmer; Roche; Sanofi; Ultivue
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Cepheid (Inst); Konica Minolta (Inst); Lilly (Inst); NanoString Technologies (Inst); Navigate Biopharma (Inst); NextCure (Inst); Perkin Elmer (Inst); Ultivue (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Bristol-Myers Squibb; NextCure; Ventana Medical Systems